Vanguard Group
VERA icon

Vanguard Group’s Vera Therapeutics VERA Stock Holding History

Vanguard Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$181M Buy
3,570,401
+379,748
+12% +$13.5M ﹤0.01% 1597
2025
Q3 		$92.7M Buy
3,190,653
+189,545
+6% +$4.38M ﹤0.01% 1887
2025
Q2 		$70.7M Buy
3,001,108
+82,685
+3% +$1.86M ﹤0.01% 1972
2025
Q1 		$70.1M Sell
2,918,423
-31,141
-1% -$1M ﹤0.01% 1950
2024
Q4 		$125M Buy
2,949,564
+369,387
+14% +$16.4M ﹤0.01% 1770
2024
Q3 		$114M Buy
2,580,177
+56,001
+2% +$2.13M ﹤0.01% 1815
2024
Q2 		$91.3M Buy
2,524,176
+375,462
+17% +$14.9M ﹤0.01% 1873
2024
Q1 		$92.7M Buy
2,148,714
+515,106
+32% +$18.4M ﹤0.01% 1904
2023
Q4 		$25.1M Buy
1,633,608
+59,218
+4% +$752K ﹤0.01% 2492
2023
Q3 		$21.6M Buy
1,574,390
+134,125
+9% +$2.3M ﹤0.01% 2513
2023
Q2 		$23.1M Buy
1,440,265
+45,414
+3% +$410K ﹤0.01% 2532
2023
Q1 		$10.8M Buy
1,394,851
+627,318
+82% +$4.84M ﹤0.01% 2892
2022
Q4 		$14.9M Buy
767,533
+8,701
+1% +$158K ﹤0.01% 2775
2022
Q3 		$16.2M Buy
758,832
+81,895
+12% +$1.53M ﹤0.01% 2722
2022
Q2 		$9.21M Buy
676,937
+58,934
+10% +$1.03M ﹤0.01% 3040
2022
Q1 		$14.5M Buy
618,003
+229,025
+59% +$4.93M ﹤0.01% 2952
2021
Q4 		$10.4M Buy
388,978
+143,143
+58% +$3.17M ﹤0.01% 3178
2021
Q3 		$4.26M Buy
245,835
+193,567
+370% +$3.46M ﹤0.01% 3760
2021
Q2 		$693K Buy
+52,268
New +$812K ﹤0.01% 4214

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group's VERA Position: Q4 2025 in Review

Vanguard Group increased its Vera Therapeutics (VERA) stake by 12% in Q4 2025, buying an estimated $13.5M and bringing the position to 3,570,401 shares worth $181M. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Vanguard Group first reported a position in VERA in Q2 2021 and has held it in 19 quarters since. 214 funds tracked by Wall St. Rank hold VERA as of Q4 2025.

  • Vanguard Group held 3,570,401 shares of Vera Therapeutics worth $181M as of Q4 2025.
  • Vanguard Group bought 379,748 Vera Therapeutics shares in Q4 2025, an estimated $13.5M.
  • Vera Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1597 holding.
  • Vanguard Group first reported a position in Vera Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • 214 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.